title: Resistance exercise, muscle loading/unloading and the control of muscle mass.
abstract: Muscle mass is determined by the difference between the rate of protein synthesis and degradation. If synthesis is greater than degradation, muscle mass will increase (hypertrophy) and when the reverse is true muscle mass will decrease (atrophy). Following resistance exercise/increased loading there is a transient increase in protein synthesis within muscle. This change in protein synthesis correlates with an increase in the activity of protein kinase B/Akt and mTOR (mammalian target of rapamycin). mTOR increases protein synthesis by increasing translation initiation and by inducing ribosomal biogenesis. By contrast, unloading or inactivity results in a decrease in protein synthesis and a significant increase in muscle protein breakdown. The decrease in synthesis is due in part to the inactivation of mTOR and therefore a decrease in translation initiation, but also to a decrease in the rate of translation elongation. The increase in degradation is the result of a co-ordinated response of the calpains, lysosomal proteases and the ATP-dependent ubiquitin-proteosome. Caspase 3 and the calpains act upstream of the ubiquitin-proteosome system to assist in the complete breakdown of the myofibrillar proteins. Two muscle specific E3 ubiquitin ligases, MuRF1 and MAFbx/atrogen-1, have been identified as key regulators of muscle atrophy. In this chapter, these pathways and how the balance between anabolism and catabolism is affected by loading and unloading will be discussed.
authors.affiliation: Division of Molecular Physiology, University of Dundee, Dundee UK. k.baar@dundee.ac.uk
authors.forename: Keith
authors.initials: K
authors.lastname: Baar
authors.forename: Gustavo
authors.initials: G
authors.lastname: Nader
authors.forename: Sue
authors.initials: S
authors.lastname: Bodine
mesh_terms: D000818:Animals; D015444:Exercise / Q000502:physiology*; D006801:Humans; D006984:Hypertrophy; D008954:Models, Biological; D009124:Muscle Proteins / Q000096:biosynthesis; D018482:Muscle, Skeletal / Q000033:anatomy & histology* / Q000473:pathology / Q000502:physiology*; D009133:Muscular Atrophy / Q000473:pathology / Q000503:physiopathology; D010766:Phosphorylation; D005082:Physical Exertion / Q000502:physiology; D011494:Protein Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D016474:Weight-Bearing
chemical_list: D009124:Muscle Proteins; D011494:Protein Kinases; C546842:MTOR protein, human; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases